ARAMARK (ARMK) Stock Analysis
Market Closed
Sector: Consumer Cyclical · Industry: Retail-Eating Places
What's happening with ARMK
Price History
5-Year Weekly Candlestick Chart
Profile
Strong earnings quality; profitability, financial health, growth and valuation lag behind.
How is each axis scored?
- Valuation47/100 · Weak
- P/E vs own history (68th pct)5/25
- FCF yield (2.6%)5/25
- P/S (0.8x)25/25
- EV/EBIT (24.5x)12/25
- Growth45/100 · Weak
- Revenue CAGR (11.2%)20/25
- Net income CAGR (n/a)0/25
- EPS CAGR 5Y (n/a)0/25
- Fwd implied growth (91.9%)25/25
- Profitability28/100 · Weak
- ROIC (7.4%)5/25
- ROE (10.9%)12/25
- Net margin (1.8%)6/25
- Operating margin (4.3%)5/25
- Financial Health37/100 · Weak
- Altman Z (1.78)10/25
- Current ratio (1.21)12/25
- Interest coverage (2.2x)10/25
- Net cash / debt (D/A 41%)5/25
- Quality97/100 · Strong
- Piotroski F (7/9)22/25
- Beneish M (-2.52)25/25
- FCF conversion (110%)25/25
- Margin stability (σ 2.2%)25/25
About ARAMARK
Aramark, founded in 1936 and headquartered in Philadelphia, Pennsylvania, is a foodservice company that provides facility management and workplace solutions. Show more
The company primarily generates revenue from its North American food and support services segment, serving clients such as schools, healthcare facilities, and entertainment venues.
Headquarters: PHILADELPHIA, PA · Employees: 278,390 · Website ↗
Analyst Consensus
Strong BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 21, 2026
Insider Transactions
Recent SEC Form 4 filings
- SellOption exercise · filed 2026-08-14-74653 sh2026-08-13
- SellOption exercise · filed 2026-08-14-57060 sh2026-08-13
- SellOption exercise · filed 2026-08-14-78689 sh2026-08-13
- SellOpen market sale · filed 2026-08-14-15389 sh2026-08-13
- SellOpen market sale · filed 2026-08-14-55245 sh2026-08-13
+3 more recent filings
Key Metrics
Financial snapshot — pillar inputs plus per-share and market context
Valuation
47D+P/E (TTM)42.1xD
Grade D: Exp.Price / TTM EPS (own statements) — vs own 5Y history: 11.6x–304.1x · 68th pct
P/FCF11.1xA
Grade A: CheapPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield2.6%C
Grade C: LowTTM FCF / Market Cap — vs own 5Y history: -1.9%–4.6% · 58th pct
P/S (TTM)0.77xA
Grade A: CheapPrice / TTM Revenue (own statements) — vs own 5Y history: 0.3x–0.9x · 91st pct
EV/EBIT24.5xC
Grade C: Exp.Enterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 15.6x–50.2x · 65th pct
EV/Sales1.0xA
Grade A: CheapEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E22.0xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio4.54xC
Grade C: Exp.Price to Book Value. Neg. equity = heavy buybacks
PEG Ratio1.82B
Grade B: FairFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield0.82%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio34.0%A
Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
28EROIC7.4%D
Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE10.9%C
Grade C: AvgReturn on Equity. Neg. equity = heavy buybacks
ROA2.8%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin1.8%D
Grade D: LowNet Income / Revenue
Operating Margin4.3%D
Grade D: LowTTM EBIT / TTM Revenue
Gross Margin4.3%D
Grade D: LowGross Profit / Revenue
FCF Margin2.0%D
Grade D: LowFCF / Revenue
True FCF Margin1.7%D
Grade D: LowTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Financial Health
37DAltman Z-Score1.78D
Grade D: DistressBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.21xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio0.83xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage2.2xD
Grade D: RiskyEBIT/Interest. >10 Strong
Debt Repayment14.3yD
Grade D: SlowYears to repay net debt via FCF
Net Debt/EBIT6.7xD
Grade D: HighLeverage. <2x Low, >4x High
Debt/Equity1.86xC
Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.08xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Growth
45D+Revenue CAGR11.2%C
Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR—
Compound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)—
Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Forward Growth91.9%A
Grade A: HighImplied 1Y EPS growth from forward P/E vs our TTM EPS. Sparse — only where forward estimates exist
Dilution (5Y)+4.8%C
Grade C: DilutiveShare count change over 5Y
SBC / Net Income17.7%C
Grade C: MedStock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.3%A
Grade A: LowTTM stock-based comp / TTM Revenue
Quality
2/10 Loss Years97A+Piotroski F-Score7/9A
Grade A: StrongFinancial strength 0–9. >7 Strong
Beneish M-Score-2.52A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion110.2%A
Grade A: StrongFCF / Net Income
Margin Stability2.2%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue2.5%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover1.39xA
Grade A: HighRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Per Share
EPS (TTM)$1.34
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$2.43
Cash & short-term investments per share (Finnhub)
Book Value / Share$11.97
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$6.09B
Total debt obligations (short + long term)
Cash & Equiv.$475.72M
Cash and short-term investments
Net Debt$5.61B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$3.28B
Shareholders' equity (book value)
Asset / Liability1.31xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$14.89B
Current Market Capitalization
Beta1.10B
Grade B: MarketPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
Takeaway
Vysoké riziko insolvencie (Altman Z-score 1,78), neúmerne dlhé splácanie dlhu (14,3 roka) a nízky FCF výnos na úrovni 2,6 % robia z ARMK neatraktívnu a vysoko rizikovú investíciu.
Takes ~14.3 years to repay net debt from free cash flow. · Current P/E of 42.1x sits at the 68th percentile of its historical range.
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Apr 2026 · Ratio snapshot Sep 22, 2026
Key Insights: ARAMARK (ARMK)
Composite verdict for ARAMARK: Vysoké riziko insolvencie (Altman Z-score 1,78), neúmerne dlhé splácanie dlhu (14,3 roka) a nízky FCF výnos na úrovni 2,6 % robia z ARMK neatraktívnu a vysoko rizikovú investíciu.. ARAMARK meets 7 of 9 Piotroski F-Score criteria, placing its fundamental strength in the top tier of US-listed stocks. Altman Z-Score of 1.78 is below the 1.81 distress threshold — an elevated financial-risk flag.
- Beneish M-Score of -2.52 suggests a low likelihood of earnings manipulation.
- Takes ~14.3 years to repay net debt from free cash flow.
- ARAMARK posted a net loss in 2 of 10 available completed fiscal years (2016–2025).
See how ARMK ranks on the Capex Tracker — top 50 capital spenders compared.
No significant market moves for ARMK in the last 30 days.
See ARMK move history →Frequently Asked Questions about ARMK
Is ARMK stock a buy right now?
PreMarketPrice's quantitative model rates ARAMARK's financial health at 37/100 — Vysoké riziko insolvencie (Altman Z-score 1,78), neúmerne dlhé splácanie dlhu (14,3 roka) a nízky FCF výnos na úrovni 2,6 % robia z ARMK neatraktívnu a vysoko rizikovú investíciu.. This is a data-driven snapshot of fundamentals, not investment advice.
Is ARMK stock overvalued?
ARAMARK trades at a trailing P/E of 42.1 and our valuation score rates it 47/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does ARAMARK report earnings?
No confirmed earnings date is currently scheduled for ARMK. The Earnings section lists recent reports and updates as dates are announced.
What sector does ARAMARK operate in?
ARAMARK operates in the Consumer Cyclical sector, within the Retail-Eating Places industry. The Related Stocks section lists sector peers for comparison.
What does ARAMARK do?
Aramark, founded in 1936 and headquartered in Philadelphia, Pennsylvania, is a foodservice company that provides facility management and workplace solutions.
About ARAMARK (ARMK) Stock
ARAMARK (ARMK) is a US-listed stock operating in the Consumer Cyclical sector, specifically the Retail-Eating Places industry. Real-time pricing data for ARAMARK is available on this page with a market capitalization of $14.9 billion. The financial health score for ARMK is 37/100, which indicates weak financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for ARMK stock.
ARMK Stock Analysis & Key Metrics
On PreMarketPrice, you can track ARAMARK (ARMK) across multiple dimensions:
- Pre-market price & movement: Real-time ARMK stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for ARMK with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for ARAMARK across multiple reporting periods.
- Financial health score: A composite score of 37/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for ARMK.
- Sector peers: Compare ARMK against 10 other consumer cyclical stocks on key financial metrics.
Is ARMK a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate ARAMARK (ARMK) as an investment. The financial health score of 37/100 suggests weak financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.ARAMARK (ARMK) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.